LY 353381

Known as: LY-353381, LY353381 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2007
02419982007

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Selective oestrogen receptor modulators (SERMs) are compounds with a mixed agonist/antagonist activity on oestrogen receptors. An… (More)
Is this relevant?
2003
2003
Arzoxifene (ARZ) is a selective estrogen receptor (ER) modulator with greater bioavailability than raloxifene which is being… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 5
Is this relevant?
Review
2003
Review
2003
BACKGROUND This randomized, double-blind, phase II study assessed two doses of the selective estrogen receptor modulator… (More)
Is this relevant?
Review
2003
Review
2003
PURPOSE To select a daily dose of arzoxifene (LY353381), a selective estrogen receptor modulator, for use in future studies in… (More)
Is this relevant?
2003
2003
OBJECTIVES The goal of this study was to determine response rate and evaluate toxicity of LY353381 (arzoxifene) in patients with… (More)
Is this relevant?
2001
2001
PURPOSE Cross-resistance is the primary issue facing the evaluation of new antiestrogens to treat metastatic breast cancer… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2000
2000
Recent data indicate that insulin-like growth factor I (IGF-I) may have a function in mediating the mitogenic effects of 17beta… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2000
2000
This symposium focused on trials conducted primarily on patients with metastatic breast cancer with the aim of defining the… (More)
Is this relevant?
Review
1999
Review
1999
Selective estrogen receptor modulators (SERMs) are structurally diverse compounds that bind to estrogen receptors (ER) and elicit… (More)
Is this relevant?
1998
1998
LY353381 x HCl is a benzothiophene analog that is structurally related to raloxifene with potent selective estrogen receptor… (More)
Is this relevant?